journal
MENU ▼
Read by QxMD icon Read
search

Future Microbiology

journal
https://www.readbyqxmd.com/read/28345957/xyloglucan-hibiscus-and-propolis-for-the-prevention-of-urinary-tract-infections-results-of-in-vitro-studies
#1
Benito Fraile, Javier Alcover, Mar Royuela, David Rodríguez, Concepción Chaves, Ricardo Palacios, Núria Piqué
AIM: To assess the properties of a medical device containing xyloglucan, propolis and hibiscus to create a bioprotective barrier to avoid the contact of uropathogenic Escherichia coli strains on cell walls in models of intestinal (CacoGoblet) and uroepithelial (RWPE-1) cells (derived from normal human prostate epithelium). MATERIALS & METHODS: Two uropathogenic E. coli strains (expressing type 1 fimbriae and P fimbriae) were used to assess, by electronic microscopy and ELISA, the barrier properties of the medical device...
March 27, 2017: Future Microbiology
https://www.readbyqxmd.com/read/28343421/in-vitro-and-in-vivo-fitness-costs-associated-with-mycobacterium-tuberculosis-rpob-mutation-h526d
#2
Dalin Rifat, Victoria L Campodónico, Jing Tao, James A Miller, Alpaslan Alp, Yufeng Yao, Petros C Karakousis
AIM: There is controversy regarding the potential fitness costs of rifampicin (RIF) resistance-conferring mutations in the Mycobacterium tuberculosis (Mtb) rpoB gene. We characterized the pathogenicity of an Mtb RpoB H526D mutant. MATERIALS & METHODS: A mutant containing the RpoB H526D mutation was isolated from wild-type Mtb grown on RIF-containing plates and complemented for determination of in vitro and in vivo fitness costs. RESULTS: The RpoB H526D mutant showed reduced survival relative to control strains during progressive hypoxia and delayed growth following resuscitation from nutrient starvation (p < 0...
March 27, 2017: Future Microbiology
https://www.readbyqxmd.com/read/28339296/synthetic-parasites-a-successful-mucosal-nanoparticle-vaccine-against-toxoplasma-congenital-infection-in-mice
#3
Céline Ducournau, Thi Tl Nguyen, Rodolphe Carpentier, Isabelle Lantier, Stéphanie Germon, Flavien Précausta, Pierre-Jean Pisella, Hervé Leroux, Nathalie Van Langendonck, Didier Betbeder, Isabelle Dimier-Poisson
AIM: Development of protein vaccine to prevent congenital infection is a major public health priority. Our goal is the design of mucosal synthetic pathogen inducing protective immune responses against congenital toxoplasmosis. MATERIALS & METHODS: Mice were immunized intranasally, establishing pregnancy and challenging orally. Placental immune response, congenital infection, pup growth, parasitic load rates were studied. RESULTS: Pups born to vaccinated infected dams had significantly fewer brain cysts, no intraocular inflammation and normal growth...
March 24, 2017: Future Microbiology
https://www.readbyqxmd.com/read/28339295/antifungal-plant-defensins-increased-insight-in-their-mode-of-action-as-a-basis-for-their-use-to-combat-fungal-infections
#4
Tanne L Cools, Caroline Struyfs, Bruno Pa Cammue, Karin Thevissen
Plant defensins are small, cationic peptides with a highly conserved 3D structure. They have been studied extensively in the past decades. Various biological activities have been attributed to plant defensins, such as anti-insect and antimicrobial activities, but they are also known to affect ion channels and display antitumor activity. This review focuses on the structure, biological activity and antifungal mode of action of some well-characterized plant defensins, with particular attention to their fungal membrane target(s), their induced cell death mechanisms as well as their antibiofilm activity...
March 24, 2017: Future Microbiology
https://www.readbyqxmd.com/read/28339294/rapid-assessment-of-antimicrobial-resistance-prevalence-using-a-lot-quality-assurance-sampling-approach
#5
Frank van Leth, Casper den Heijer, Mariëlle Beerepoot, Ellen Stobberingh, Suzanne Geerlings, Constance Schultsz
AIM: Increasing antimicrobial resistance (AMR) requires rapid surveillance tools, such as Lot Quality Assurance Sampling (LQAS). MATERIALS & METHODS: LQAS classifies AMR as high or low based on set parameters. We compared classifications with the underlying true AMR prevalence using data on 1335 Escherichia coli isolates from surveys of community-acquired urinary tract infection in women, by assessing operating curves, sensitivity and specificity. RESULTS: Sensitivity and specificity of any set of LQAS parameters was above 99% and between 79 and 90%, respectively...
March 24, 2017: Future Microbiology
https://www.readbyqxmd.com/read/28339292/thymbra-capitata-essential-oil-as-potential-therapeutic-agent-against-gardnerella-vaginalis-biofilm-related-infections
#6
Daniela Machado, Carlos Gaspar, Ana Palmeira-de-Oliveira, Carlos Cavaleiro, Lígia Salgueiro, José Martinez-de-Oliveira, Nuno Cerca
AIM: To evaluate the antibacterial activity of Thymbra capitata essential oil and its main compound, carvacrol, against Gardnerella vaginalis grown planktonically and as biofilms, and its effect of vaginal lactobacilli. MATERIALS & METHODS: Minimal inhibitory concentration, minimal lethal concentration determination and flow cytometry analysis were used to assess the antibacterial effect against planktonic cells. Antibiofilm activity was measured through quantification of biomass and visualization of biofilm structure by confocal laser scanning microscopy...
March 24, 2017: Future Microbiology
https://www.readbyqxmd.com/read/28339291/bronchial-microbiome-pa-biofilm-forming-capacity-and-exacerbation-in-severe-copd-patients-colonized-by-p-aerugirona
#7
Marian Garcia-Nuñez, Sara Marti, Carmen Puig, Vicente Perez-Brocal, Laura Millares, Salud Santos, Carmen Ardanuy, Andres Moya, Josefina Liñares, Eduard Monsó
AIM: The bronchial microbiome of severe chronic obstructive pulmonary disease patients colonized by Pseudomonas aeruginosa was analyzed using 16S rRNA gene sequencing to identify differences related to biofilm-forming capacity. PATIENTS & METHODS: Patient sputum samples from 21 patients were studied. RESULTS: Statistically significant differences related to biofilm-forming capacity were only found for genera with relative abundances <1%, and Fusobacterium was over-represented when biofilm-forming capacity was high...
March 24, 2017: Future Microbiology
https://www.readbyqxmd.com/read/28339290/preventing-the-spread-of-infectious-diseases-antivirulents-versus-antibiotics
#8
Menachem Shoham, Michael Greenberg
No abstract text is available yet for this article.
March 24, 2017: Future Microbiology
https://www.readbyqxmd.com/read/28338347/ceftazidime-avibactam-novel-antimicrobial-combination-for-the-treatment-of-complicated-urinary-tract-infections
#9
Jakhongir F Alidjanov, Moritz Fritzenwanker, Ivan Hoffman, Florian M Wagenlehner
Ceftazidime-avibactam is a combination of a third-generation cephalosporin and a novel non-beta-lactam beta-lactamase inhibitor. This combination was recently recommended for the treatment of complicated urinary tract infections, including acute pyelonephritis, in adults with limited or no alternative treatment options. The current review is aimed to determine activity, efficacy and safety of ceftazidime-avibactam in the treatment of patients with complicated urinary tract infections.
March 24, 2017: Future Microbiology
https://www.readbyqxmd.com/read/28326813/breakthrough-candidemia-in-children-clinical-and-microbiological-characteristics-therapeutic-strategies-and-impact-on-outcomes
#10
Mei-Yin Lai, Jen-Fu Hsu, Shih-Ming Chu, I-Hsyuan Wu, Hsuan-Rong Huang, Chun-Chih Lin, I-Ta Lee, Ming-Chou Chiang, Ren-Huei Fu, Ming-Horng Tsai
AIM: To assess the characteristics, treatments, risk factors and outcomes of breakthrough candidemia in children. MATERIALS & METHODS: Episodes of breakthrough candidemia in children were compared with the remaining episodes in a 13-year cohort study. RESULTS: Out of 319 episodes, 45 (14.1%) were breakthrough candidemia. Breakthrough candidemia occurred in patients with more acutely ill conditions, and the majority was caused by non-albicans Candida species (73...
March 13, 2017: Future Microbiology
https://www.readbyqxmd.com/read/28326810/corrigendum
#11
(no author information available yet)
No abstract text is available yet for this article.
March 9, 2017: Future Microbiology
https://www.readbyqxmd.com/read/28326812/evaluation-of-reticulated-gelatin-hibiscus-propolis-against-intestinal-commensal-species-commonly-associated-with-urinary-tract-infections
#12
Maïwenn Olier, Soraya Sekkal, Cherryl Harkat, Hélène Eutamene, Vassilia Theodorou
AIM: Reticulated gelatin (RG), hibiscus and propolis (RGHP) is a medical device that can reduce the bacterial adherence to epithelial cultured cells and invasion by enteropathogens, thus gathering relevant properties to decrease the risk of urinary tract infections (UTIs). We aimed at evaluating in Wistar rats the efficacy of RGHP, RG and vehicle against intestinal commensals commonly involved in UTIs. METHODS: Animals received orally (with supplemental Na2CO3): RGHP 1540 mg/day/rat; RG 500 mg/day/rat or vehicle...
March 3, 2017: Future Microbiology
https://www.readbyqxmd.com/read/28326811/combinations-of-avibactam-and-carbapenems-exhibit-enhanced-potencies-against-drug-resistant-mycobacterium-abscessus
#13
Amit Kaushik, Chhavi Gupta, Stefanie Fisher, Elizabeth Story-Roller, Christos Galanis, Nicole Parrish, Gyanu Lamichhane
AIM: The objective of this study was to assess if avibactam, a new β-lactamase inhibitor, can restore the potency of carbapenems, a sub-class of β-lactams, against Mycobacterium abscessus clinical isolates. MATERIALS & METHODS: Twenty-eight M. abscessus clinical isolates that are resistant to multiple drugs currently used to treat its infection were included. MIC of carbapenems alone and in combination with avibactam against these strains were determined. RESULTS: Tebipenem, an oral carbapenem, and ertapenem and panipenem exhibited the greatest shift in MIC when supplemented with avibactam...
February 16, 2017: Future Microbiology
https://www.readbyqxmd.com/read/28191796/the-cost-of-treating-mucormycosis-with-isavuconazole-compared-with-standard-therapy-in-the-uk
#14
Emma Bagshaw, Daniel Kuessner, Jan Posthumus, Cesar Escrig, Michael Blackney, Sebastian Marcel Heimann, Oliver Andreas Cornely
AIM: Mucormycosis is a fungal infection associated with high mortality. Until recently, the only licensed treatments were amphotericin B (AMB) formulations. Isavuconazole (ISAV) is a new mucormycosis treatment. A UK-based economic model explored treatment costs with ISAV versus liposomal AMB followed by posaconazole. MATERIALS & METHODS: As a matched case-control analysis showed similar efficacy for ISAV and AMB, a cost-minimization approach was taken. Direct costs - drug acquisition, monitoring and administration, and hospitalization costs - were estimated from the National Health Service perspective...
February 13, 2017: Future Microbiology
https://www.readbyqxmd.com/read/28111984/effects-of-meropenem-exposure-in-persister-cells-of-acinetobacter-calcoaceticus-baumannii
#15
Stephanie Wagner Gallo, Bruna Kern Donamore, Vany Elisa Pagnussatti, Carlos Alexandre Sanchez Ferreira, Sílvia Dias de Oliveira
AIM: To evaluate the influence of meropenem in the Acinetobacter calcoaceticus-baumannii (ACB) persister levels. METHODS: Persister levels in planktonic and biofilm cultures from ACB isolates were evaluated after exposure to different meropenem concentrations. RESULTS: A high variability of persister fractions was observed among the isolates cultured under planktonic and biofilm conditions. Meropenem concentration did not influence persister fractions, even when far above the MIC...
January 23, 2017: Future Microbiology
https://www.readbyqxmd.com/read/28106479/how-can-nanosensors-detect-bacterial-contamination-before-it-ever-reaches-the-dinner-table
#16
Tuhina Banerjee, Tyler Shelby, Santimukul Santra
No abstract text is available yet for this article.
January 20, 2017: Future Microbiology
https://www.readbyqxmd.com/read/28106477/thymosin-alpha-1-and-hiv-1-recent-advances-and-future-perspectives
#17
Claudia Matteucci, Sandro Grelli, Emanuela Balestrieri, Antonella Minutolo, Ayele Argaw-Denboba, Beatrice Macchi, Paola Sinibaldi-Vallebona, Carlo Federico Perno, Antonio Mastino, Enrico Garaci
In spite of the consistent benefits for HIV-1 infected patients undergoing antiretroviral therapy, a complete immune reconstitution is usually not achieved. Actually, antiretroviral therapy may be frequently accompanied by immunological unresponsiveness, persistent inflammatory conditions and inefficient cytotoxic T-cell response. Thymosin alpha 1 is a thymic peptide that demonstrates a peculiar ability to restore immune system homeostasis in different physiological and pathological conditions (i.e., infections, cancer, immunodeficiency, vaccination and aging) acting as multitasking protein depending on the host state of inflammation or immune dysfunction...
January 20, 2017: Future Microbiology
https://www.readbyqxmd.com/read/28106464/glycogen-a-major-player-for-bacterial-survival-and-awakening-from-dormancy
#18
Alexander Klotz, Karl Forchhammer
No abstract text is available yet for this article.
January 20, 2017: Future Microbiology
https://www.readbyqxmd.com/read/28287302/cutaneous-wound-biofilm-and-the-potential-for-electrical-stimulation-in-management-of-the-microbiome
#19
Mohammed Ashrafi, Mohamed Baguneid, Teresa Alonso-Rasgado, Riina Rautemaa-Richardson, Ardeshir Bayat
Infection contributes significantly to delayed cutaneous wound healing, which impacts patient care. External application of electrical stimulation (ES) has beneficial effects on wound repair and regeneration. The majority of studies to date have explored ES in relation to planktonic microorganisms, yet evidence indicates that bacteria in chronic wounds reside as antibiotic-resistant polymicrobial biofilms, which contribute to impairing wound healing. Culture-independent sequencing techniques have revolutionized our understanding of the skin microbiome and allowed a more accurate determination of microbial taxa and their relative abundance in wounds allowing a greater understanding of the host-microbial interface...
March 2017: Future Microbiology
https://www.readbyqxmd.com/read/28287301/antibiotics-v2-0-computational-and-synthetic-biology-approaches-to-combat-antibiotic-resistance
#20
Eamonn P Culligan, Roy D Sleator
No abstract text is available yet for this article.
March 2017: Future Microbiology
journal
journal
41395
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"